Results 271 to 280 of about 673,896 (307)

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Iain B Mcinnes, Philip J Mease, Bruce W Kirkham   +2 more
exaly  

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Lancet, The, 2017
B G Feagan, Julian Panes, Arthur Kaser
exaly  

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Lancet, The, 2012
Daniel F Freitag, John Gregson, Peter Willeit   +2 more
exaly  

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Nature Reviews Drug Discovery, 2012
Charles A Dinarello, Anna Simon, Jos W M Van Der Meer   +2 more
exaly  

Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups

Lancet, The, 1993
Sc Donnelly
exaly  

Interleukin-5 Receptor

2019
Satoshi Takaki, Yoshiyuki Murata, Akira Tominaga, Kiyoshi Takatsu   +3 more
openaire   +1 more source

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

Lancet, The, 2012
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker   +2 more
exaly  

Interleukin-5 Antagonism

2001
Maggie J. Leckie, Christoph Walker
openaire   +1 more source

Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis

Lancet, The, 2004
Paul S Mcnamara
exaly  

Interleukin-5

2006
openaire   +1 more source